Literature DB >> 23075283

Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.

Kuan-Chung Chen1, Yi-Ru Jian, Mao-Feng Sun, Tung-Ti Chang, Cheng-Chun Lee, Calvin Yu-Chian Chen.   

Abstract

Silent information regulator 1 (Sirt1), a class III nicotinamide adenine dinucleotide dependent histone deacetylases, is important in cardioprotection, neuroprotection, metabolic disease, calorie restriction, and diseases associated with aging. Traditional Chinese Medicine (TCM) compounds from TCM Database@Taiwan ( http://tcm.cmu.edu.tw/ ) were employed for screening potent Sirt1 agonists, and molecular dynamics (MD) simulation was implemented to simulate ligand optimum docking poses and protein structure under dynamic conditions. TCM compounds such as (S)-tryptophan-betaxanthin, 5-O-feruloylquinic acid, and RosA exhibited good binding affinity across different computational methods, and their drug-like potential were validated by MD simulation. Docking poses indicate that the carboxylic group of the three candidates generated H-bonds with residues in the protein chain from Ser441 to Lys444 and formed H-bond, π-cation interactions, or hydrophobic contacts with Phe297 and key active residue, His363. During MD, stable π-cation interactions with residues Phe273 or Arg274 were formed by (S)-tryptophan-betaxanthin and RosA. All candidates were anchored to His363 by stable π- or H-bonds. Hence, we propose (S)-tryptophan-betaxanthin, 5-O-feruloylquinic acid, and RosA as potential lead compounds that can be further tested in drug development process for diseases associated with aging An animated interactive 3D complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:28.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23075283     DOI: 10.1080/07391102.2012.726191

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  14 in total

1.  In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.

Authors:  Kuan-Chung Chen; Wen-Yuan Lee; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

2.  Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine.

Authors:  Yung-An Tsou; Hung-Jin Huang; Wesley Wen-Yang Lin; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-02       Impact factor: 2.629

3.  Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.

Authors:  Kuan-Chung Chen; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-29       Impact factor: 2.629

4.  Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.

Authors:  Wen-Yuan Lee; Kuan-Chung Chen; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

5.  In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.

Authors:  Hung-Jin Huang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

6.  Treatment of acute lymphoblastic leukemia from traditional chinese medicine.

Authors:  Ya-Li Hsiao; Pei-Chun Chang; Hung-Jin Huang; Chia-Chen Kuo; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-22       Impact factor: 2.629

7.  Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.

Authors:  Kuen-Bao Chen; Hsin-Yi Chen; Kuan-Chung Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

8.  In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.

Authors:  Kuan-Chung Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

9.  Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.

Authors:  Kuan-Chung Chen; Yu-Cheng Liu; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

10.  Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine.

Authors:  Hung-Jin Huang; Hsin-Yi Chen; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.